Literature DB >> 31179822

A microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles.

Lei Li1,2, Kurtulus Gokduman1, Aslihan Gokaltun1,3, Martin L Yarmush1,4, Osman Berk Usta1.   

Abstract

Aim: To develop a practical microfluidic 3D hepatocyte chip for hepatotoxicity testing of nanoparticles using proof of concept studies providing first results of the potential hepatotoxicity of superparamagnetic iron oxide nanoparticles (SPION) under microfluidic conditions.
Methods: A microfluidic 3D hepatocyte chip with three material layers, which contains primary rat hepatocytes, has been fabricated and tested using different concentrations (50, 100 and 200 μg/ml) of SPION in 3-day (short-term) and 1-week (long-term) cultures.
Results: Compared with standard well plates, the hepatocyte chip with flow provided comparable viability and significantly higher liver-specific functions, up to 1 week. In addition, the chip recapitulates the key physiological responses in the hepatotoxicity of SPION.
Conclusion: Thus, the developed 3D hepatocyte chip is a robust and highly sensitive platform for investigating hepatotoxicity profiles of nanoparticles.

Entities:  

Keywords:  3D hepatocyte chip; albumin; nanotoxicology; primary rat hepatocytes; superparamagnetic iron oxide nanoparticles (SPION); urea

Mesh:

Substances:

Year:  2019        PMID: 31179822      PMCID: PMC7006797          DOI: 10.2217/nnm-2019-0086

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  55 in total

Review 1.  Chip-based liver equivalents for toxicity testing--organotypicalness versus cost-efficient high throughput.

Authors:  Eva-Maria Materne; Alexander G Tonevitsky; Uwe Marx
Journal:  Lab Chip       Date:  2013-09-21       Impact factor: 6.799

2.  Low-cost rapid prototyping of flexible microfluidic devices using a desktop digital craft cutter.

Authors:  Po Ki Yuen; Vasiliy N Goral
Journal:  Lab Chip       Date:  2009-11-24       Impact factor: 6.799

3.  Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice.

Authors:  Lin Yang; Huijuan Kuang; Wanyi Zhang; Zoraida P Aguilar; Yonghua Xiong; Weihua Lai; Hengyi Xu; Hua Wei
Journal:  Nanoscale       Date:  2015-01-14       Impact factor: 7.790

4.  Manipulating directional cell motility using intracellular superparamagnetic nanoparticles.

Authors:  Michael Bradshaw; Tristan D Clemons; Diwei Ho; Lucía Gutiérrez; Francisco J Lázaro; Michael J House; Timothy G St Pierre; Mark W Fear; Fiona M Wood; K Swaminathan Iyer
Journal:  Nanoscale       Date:  2015-03-21       Impact factor: 7.790

5.  Polymeric vector-mediated gene transfection of MSCs for dual bioluminescent and MRI tracking in vivo.

Authors:  Chun Wu; Jingguo Li; Pengfei Pang; Jingjing Liu; Kangshun Zhu; Dan Li; Du Cheng; Junwei Chen; Xintao Shuai; Hong Shan
Journal:  Biomaterials       Date:  2014-06-26       Impact factor: 12.479

Review 6.  Cytotoxicity of nanoparticles.

Authors:  Nastassja Lewinski; Vicki Colvin; Rebekah Drezek
Journal:  Small       Date:  2008-01       Impact factor: 13.281

Review 7.  Bioengineering of liver assist devices.

Authors:  Arno W Tilles; François Berthiaume; Martin L Yarmush; Ronald G Tompkins; Mehmet Toner
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

8.  Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance.

Authors:  Srivatsan Kidambi; Rubin S Yarmush; Eric Novik; Piyun Chao; Martin L Yarmush; Yaakov Nahmias
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-31       Impact factor: 11.205

9.  Supercooling as a viable non-freezing cell preservation method of rat hepatocytes.

Authors:  O Berk Usta; Yeonhee Kim; Sinan Ozer; Bote G Bruinsma; Jungwoo Lee; Esin Demir; Tim A Berendsen; Catheleyne F Puts; Maria-Louisa Izamis; Korkut Uygun; Basak E Uygun; Martin L Yarmush
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

10.  A perfusion incubator liver chip for 3D cell culture with application on chronic hepatotoxicity testing.

Authors:  Fang Yu; Rensheng Deng; Wen Hao Tong; Li Huan; Ng Chan Way; Anik IslamBadhan; Ciprian Iliescu; Hanry Yu
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more
  6 in total

1.  Microphysiological Systems: Next Generation Systems for Assessing Toxicity and Therapeutic Effects of Nanomaterials.

Authors:  Nureddin Ashammakhi; Mohammad Ali Darabi; Betül Çelebi-Saltik; Rumeysa Tutar; Martin C Hartel; Junmin Lee; Saber Hussein; Marcus J Goudie; Mercedes Brianna Cornelius; Mehmet R Dokmeci; Ali Khademhosseini
Journal:  Small Methods       Date:  2019-11-11

Review 2.  Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review.

Authors:  Jiu Deng; Wenbo Wei; Zongzheng Chen; Bingcheng Lin; Weijie Zhao; Yong Luo; Xiuli Zhang
Journal:  Micromachines (Basel)       Date:  2019-10-07       Impact factor: 2.891

Review 3.  Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity.

Authors:  Rick Xing Ze Lu; Milica Radisic
Journal:  Bioact Mater       Date:  2021-02-15

4.  Long-term maintenance of functional primary human hepatocytes in 3D gelatin matrices produced by solution blow spinning.

Authors:  Mariliis Klaas; Kaidi Möll; Kristina Mäemets-Allas; Mart Loog; Martin Järvekülg; Viljar Jaks
Journal:  Sci Rep       Date:  2021-10-11       Impact factor: 4.379

Review 5.  A Review on Conventional and Advanced Methods for Nanotoxicology Evaluation of Engineered Nanomaterials.

Authors:  Anny Leudjo Taka; Charlotte Mungho Tata; Michael John Klink; Xavier Yangkou Mbianda; Fanyana Moses Mtunzi; Eliazer Bobby Naidoo
Journal:  Molecules       Date:  2021-10-29       Impact factor: 4.411

Review 6.  Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.

Authors:  Melissa Anne Tutty; Dania Movia; Adriele Prina-Mello
Journal:  Drug Deliv Transl Res       Date:  2022-05-04       Impact factor: 5.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.